AKYÜZLÜ, D. Et Al. 2024. OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859. NEUROSCIENCE LETTERS , vol.834 .

AKYÜZLÜ, D., Ozkan-Kotilog, S., Man, M. D., & BAL, C., (2024). OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859. NEUROSCIENCE LETTERS , vol.834.

AKYÜZLÜ, DİLEK Et Al. "OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859," NEUROSCIENCE LETTERS , vol.834, 2024

AKYÜZLÜ, DİLEK Et Al. "OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859." NEUROSCIENCE LETTERS , vol.834, 2024

AKYÜZLÜ, D. Et Al. (2024) . "OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859." NEUROSCIENCE LETTERS , vol.834.

@article{article, author={DİLEK AKYÜZLÜ Et Al. }, title={OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859}, journal={NEUROSCIENCE LETTERS}, year=2024}